Cambridge Newswire

Comprehensive Real-Time News Feed for Cambridge, MA.

Results 1 - 20 of 84 for "u:bloomberg.com" in Cambridge, MA

  1. Remodels Boom as Owners Choose Upgrades Over New HousesRead the original story

    10 hrs ago | Bloomberg

    Cory Laws considered selling his house and moving to an updated property with his girlfriend. But he likes his neighborhood, so he decided to spend as much as $100,000 to remodel the Herndon, Virginia, home.

    Comment?

  2. Harvard Beats Stanford, Raising Record $1.16 Billion in a YearRead the original story

    Yesterday | Bloomberg

    Harvard University raised a record $1.16 billion in donations in a single year, beating rival Stanford for the first time in a decade. Harvard's haul, the largest ever in higher education, represents more than the entire endowments of all but about 70 U.S. colleges.

    Comment?

  3. Google, Biogen Seek Reasons for Advance of Multiple SclerosisRead the original story

    Tuesday | The Washington Post

    Google Inc., expanding its foray into medical research, will join multiple sclerosis drugmaker Biogen Idec Inc. to study environmental and biological contributors to the debilitating disease's progression. The collaboration is the second major pharmaceutical partnership for the life science division of Google X labs, which has hatched Google Glass and self-driving cars.

    Comment?

  4. Roche's Franz Says Impact of Franc Surge Largely MitigatedRead the original story

    Thursday Jan 22 | The Washington Post

    "In the case of Roche, there is a particular influence of the exchange rate -- the earthquake we had last week," Franz said in an interview today at the World Economic Forum's annual meeting in Davos, Switzerland. Less than 20 percent of Roche's costs are in francs, he said.

    Comment?

  5. In Vanguard's Shadow, a Small Firm Wins Big Tweaking IndexesRead the original story

    Wednesday Jan 14 | The Washington Post

    Before getting the go-ahead to invest in Dimensional's products last year, Balunek, a financial adviser from Cleveland, had to submit to an interview, fill out a questionnaire and pay out of her own pocket for a two-day trip to Austin, Texas, where she listened to the company's executives explain how they do business. The process, which Balunek described as "intense," took about five months.

    Comment?

  6. In Vanguard's Shadow, a Small Firm Scores Big Tweaking IndexingRead the original story

    Wednesday Jan 14 | The Washington Post

    When Molly Bernet Balunek expressed interest in putting money into mutual funds run by Dimensional Fund Advisors, she didn't know she was in for a rigorous courtship ritual. Before getting the go-ahead to invest in Dimensional's products last year, Balunek, a financial adviser from Cleveland, had to submit to an interview, fill out a questionnaire and pay out of her own pocket for a two-day trip to Austin, Texas, where she listened to the company's executives explain how they do business.

    Comment?

  7. Roche Plans to Acquire $1 Billion Stake in Genomics CompanyRead the original story

    Monday Jan 12 | The Washington Post

    Roche will buy 5 million new shares of Cambridge, Massachusetts-based Foundation for $50 each and make an offer to purchase stock from existing investors for the same price to take its stake to as much as 56 percent, the companies said in a statement today. The offer values Foundation shares at more than double their closing price last week.

    Comment?

  8. Roche Plans to Acquire $1 Billion Stake in U.S. Genomics CompanyRead the original story

    Monday Jan 12 | The Washington Post

    Roche Holding AG plans to pay more than $1 billion for a majority stake in Foundation Medicine Inc. to get access to genomic tests for screening tumors and to develop a new generation of treatments for fighting cancer. Roche will buy 5 million new shares of Cambridge, Massachusetts-based Foundation for $50 each and make an offer to purchase stock from existing investors for the same price to take its stake to as much as 56 percent, the companies said in a statement today.

    Comment?

  9. Roche Plans $1 Billion Stake in Foundation Genomics CompanyRead the original story

    Monday Jan 12 | The Washington Post

    Roche will buy 5 million newly issued shares of Foundation for $50 each, then begin an offer for about half of the existing stock for the same price, the companies said in a statement today. The proposal is 109 percent above Foundation's closing stock price last week.

    Comment?

  10. Biogen MS Drug Shows Some Promise in Repairing Eye Nerve DamageRead the original story

    Thursday Jan 8 | The Washington Post

    Biogen Idec Inc.'s experimental drug for multiple sclerosis showed signs that it could help repair nerve damage in patients' eyes, a tentatively positive step for a drug aimed at reversing progression of the disease. In a mid-stage trial of 82 patients, Biogen's drug showed a 34 percent improvement in those who completed the study.

    Comment?

  11. Hong Kong's Lee Gives $118 Million to MIT for Real Estate LabRead the original story

    Thursday Jan 8 | Bloomberg

    Hong Kong real estate developer Samuel Tak Lee gave $118 million to Massachusetts Institute of Technology to create a lab for sustainable real estate development. The gift will fund fellowships for U.S. and international students, support research on sustainable development and put the lab's curriculum online, Cambridge, Massachusetts-based MIT said in a statement.

    Comment?

  12. Summers Sees Lower Gasoline Prices If Oil Export Ban EndsRead the original story

    Sunday Jan 4 | Bloomberg

    U.S. gasoline prices would fall, not rise, if the government lifts its near-total ban on crude-oil exports, former Treasury Secretary Lawrence Summers said. The reason for the paradoxical result: domestic gasoline prices are tied to movements in Brent crude prices, not the lower West Texas Intermediate values, he told a Jan. 3 session at the American Economic Association annual meeting in Boston.

    Comment?

  13. Cuba Dissidents Want Focus to Stay on Human Rights RecordRead the original story

    Dec 18, 2014 | Bloomberg

    Americans excited about a U.S. detente with Cuba are thinking about buying cigars and visiting a colonial capital filled with Chevy's from the Eisenhower era. Dissidents want them to remember jailed protesters and human rights.

    Comment?

  14. Takeda Names Sanofi's Plump R&D Head as Yamada RetiresRead the original story

    Dec 18, 2014 | The Washington Post

    Plump, 49, senior vice president for research and translational medicine and a member of Sanofi's global leadership team, will join Takeda Feb. 1, Kazumi Kobayashi, a Takeda spokesman in Tokyo, said by telephone today. Plump, a U.S. national, will be based in Cambridge, Massachusetts, Kobayashi said.

    Comment?

  15. Apple Stops Online Sales in Russia Over Ruble FluctuationsRead the original story

    Dec 16, 2014 | The Washington Post

    The iPhone and iPad maker stopped sales from its Web store as Russia's currency lost as much as 19 percent today, with a surprise interest-rate increase failing to stem a run on the currency. The ruble briefly sank beyond 80 per dollar, and bonds and stocks also tumbled.

    Comment?

  16. U.S. Getting Rid of Oil Addiction as Price Plummets in GlutRead the original story

    Dec 11, 2014 | The Washington Post

    The U.S. is producing the most oil in 31 years, economic growth is picking up and crude prices are plunging. So why is Americans' use of petroleum waning? As the U.S. moves closer and closer to energy independence, greater fuel efficiency, changing demographics and an increase in renewables are altering the dynamic that in the past would have seen demand for gasoline climbing. 1 comment

  17. America Getting Rid of Oil Addiction as Price Plummets Amid GlutRead the original story

    Dec 10, 2014 | Bloomberg

    The U.S. is producing the most oil in 31 years, economic growth is picking up and crude prices are plunging. So why is Americans' use of petroleum waning? As the U.S. moves closer and closer to energy independence, greater fuel efficiency , changing demographics and an increase in renewables are altering the dynamic that in the past would have seen demand for gasoline climbing.

    Comment?

  18. Bluebird Soars as Gene Therapy Ends Transfusions in PatientsRead the original story

    Dec 9, 2014 | The Washington Post

    Shares of Bluebird Bio Inc. soared to an all-time high after the company said its experimental gene therapy helped four patients with an inherited blood disorder go without regular blood transfusions. The four subjects had beta thalassemia major, a genetic condition in which the body doesn't produce enough hemoglobin to carry oxygen around the circulatory system.

    Comment?

  19. MIT Pulls Physicist's Online Courses in Sexual Harassment ProbeRead the original story

    Dec 9, 2014 | Bloomberg

    Massachusetts Institute of Technology pulled the online courses of a well-known physicist after allegations that he sexually harassed at least one woman who was taking classes. MIT removed all courses and lectures by Walter Lewin from MIT OpenCourseWare and EdX, the online learning platform founded by MIT and Harvard University , it said today in a statement .

    Comment?

  20. BlueBird Soars as Gene Therapy Ends Transfusion Need in PatientsRead the original story

    Dec 8, 2014 | The Washington Post

    Shares of Bluebird Bio Inc. soared after the company said its experimental gene therapy helped four patients with an inherited blood disorder go without regular blood transfusions. The four subjects had beta thalassemia major, a genetic condition in which the body doesn't produce enough hemoglobin to carry oxygen around the circulatory system.

    Comment?

Cambridge Job Listings
View or post Cambridge job listings on Topix.
Cambridge Real Estate
News, listings, and foreclosures in Cambridge from Topix.
Cambridge Mortgages
Find mortgage rates in Cambridge on Topix.